#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Biliary neoplasm Bronchiolitis Systemic candida Splenic marginal zone lymphoma Intracranial calcification Adrenogenital syndrome Metastases to peritoneum Carcinoid syndrome Depression Germ cell cancer Pseudoxanthoma elasticum Toxic epidermal necrolysis Muscular dystrophy Synovial sarcoma recurrent Marginal zone lymphoma More trials…

    Learn about Rare Diseases

    Pemphigoid – Basic Information Biotinidase deficiency – Diagnostics Langerhans’ cell histiocytosis – Basic Information Niemann-Pick disease – Treatment SAPHO syndrome – Basic Information Sarcoma – Treatment Prader-Willi syndrome – Treatment Hereditary optic atrophy – Diagnostics Rhabdomyosarcoma – Life with Disease Hereditary hypophosphataemic rickets – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ULEFNERSEN Indocyanine Green Hydroxyzine Hydrochloride Panobinostat Cpk850 ZINC CHLORIDE Belzutifan Azelastine Hydrochloride Oxazepam Ivermectin LY3537031 Opium, Standardized Powdered GSKVX000000040033 Citalopram Hydrochloride Medi0618 Cagrilintide Pertechnetate (99Mtc) Sodium Chlorpromazine Cabergoline Tiratricol More therapies…

    Learn about Your Condition

    Fabry's disease Breast cancer in situ Retinal artery occlusion Encephalopathy neonatal Gastrointestinal melanoma Chronic hepatitis B Inner ear disorder B-cell lymphoma recurrent Pituitary tumour benign Hypotonia Multifocal motor neuropathy Epstein-Barr virus infection Relapsing multiple sclerosis Neutropenia Osteomyelitis acute More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • A Study Comparing DZD8586 to Other Treatments for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Has Returned or Not Responded

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • [(2S,5S)-5-{4-AMINO-5-[4-(2,3-DIFLUOROPHENOXY)PHENYL]IMIDAZO[5,1-F][1,2,4]TRIAZIN-7-YL}OXAN-2-YL]METHANOL
    • Bendamustine Hydrochloride
    • Idelalisib
    Italy Poland

  • A Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia to Evaluate Long-term Safety and Effectiveness

    Recruiting

    3 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Bulgaria Croatia Czechia France Germany Greece +6

  • Study of luspatercept for patients with rare inherited anemias to reduce transfusion needs and improve hemoglobin levels

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Anaemia
    Investigated Drugs:
    • Luspatercept
    France Italy

  • A Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia

    Recruiting

    3 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Bulgaria Croatia Czechia France Germany Greece +6

  • Study comparing Sucrosomial Iron and Ferric Maltol treatment for women with iron deficiency

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Iron deficiency
    Spain

  • Study of Darbepoetin Alfa to Reduce Blood Transfusion Needs During Liver Transplant Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Darbepoetin Alfa
    Spain
Previous Page
1 … 4 5 6 7 8 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!